Keith D Robertson

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 8

Top Venues

Hepatology (Baltimore, Md.)

Clinical epigenetics

Cancer medicine

Molecular oncology

Mayo Clinic Rochester

Johns Hopkins University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Mayo Clinic Rochester Jul 01 2013

United States

Professor :: Molecular Pharmacology and Experimental Therapeutics

Education History

Johns Hopkins University

United States

PHD :: Pharmacology

Cornell University

United States

BSC

Publications

Ryan A Hlady, Xia Zhao, Louis Y El Khoury, Ryan T Wagner, Aesis Luna, Kien Pham, Nikolaos T Pyrosopoulos, Dhanpat Jain, Liguo Wang, Chen Liu, Keith D Robertson
Epigenetic heterogeneity hotspots in human liver disease progression. Hepatology (Baltimore, Md.) (2024)
Ryan A Hlady, Xia Zhao, Louis Y El Khoury, Ryan T Wagner, Aesis Luna, Kien Pham, Nikolaos T Pyrosopoulos, Dhanpat Jain, Liguo Wang, Chen Liu, Keith D Robertson
Epigenetic heterogeneity hotspots in human liver disease progression. Hepatology (Baltimore, Md.) (2024)
Ryan A Hlady, Xia Zhao, Louis Y El Khoury, Ryan T Wagner, Aesis Luna, Kien Pham, Nikolaos T Pyrosopoulos, Dhanpat Jain, Liguo Wang, Chen Liu, Keith D Robertson
Epigenetic heterogeneity hotspots in human liver disease progression. Hepatology (Baltimore, Md.) (2024)
Tianchu Wang, Ryan T Wagner, Ryan A Hlady, Xiaoyu Pan, Xia Zhao, Sungho Kim, Liguo Wang, Jeong-Heon Lee, Huijun Luo, Erik P Castle, Douglas F Lake, Thai H Ho, Keith D Robertson
SETD2 loss in renal epithelial cells drives epithelial-to-mesenchymal transition in a TGF-β-independent manner. Molecular oncology (2023)
Louis Y El Khoury, Shuang Fu, Ryan A Hlady, Ryan T Wagner, Liguo Wang, Jeanette E Eckel-Passow, Erik P Castle, Melissa L Stanton, R Houston Thompson, Alexander S Parker, Thai H Ho, Keith D Robertson
Identification of DNA methylation signatures associated with poor outcome in lower-risk Stage, Size, Grade and Necrosis (SSIGN) score clear cell renal cell cancer. Clinical epigenetics 13 (1) (2021)
Ryan A Hlady, Xia Zhao, Louis Y El Khoury, Aesis Luna, Kien Pham, Qunfeng Wu, Jeong-Heon Lee, Nikolaos T Pyrsopoulos, Chen Liu, Keith D Robertson
Interferon drives hepatitis C virus scarring of the epigenome and creates targetable vulnerabilities following viral clearance. Hepatology (Baltimore, Md.) (2021)
Liguo Wang, George W Marek, Ryan A Hlady, Ryan T Wagner, Xia Zhao, Virginia C Clark, Alex Xiucheng Fan, Chen Liu, Mark Brantly, Keith D Robertson
Alpha-1 Antitrypsin Deficiency Liver Disease, Mutational Homogeneity Modulated by Epigenetic Heterogeneity With Links to Obesity. Hepatology (Baltimore, Md.) 70 (1) (2019)
Man Yang, Ryan A Hlady, Dan Zhou, Thai H Ho, Keith D Robertson
In silico DNA methylation analysis identifies potential prognostic biomarkers in type 2 papillary renal cell carcinoma. Cancer medicine 8 (12) (2019)

Keith D Robertson.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Keith D Robertson